Edition:
United Kingdom

People: Avadel Pharmaceuticals PLC (AVDL.OQ)

AVDL.OQ on NASDAQ Stock Exchange Global Market

2.60USD
10 Dec 2018
Change (% chg)

-- (--)
Prev Close
$2.60
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
43,699
52-wk High
$11.91
52-wk Low
$2.51

Kanan, Michael 

Mr. Michael F. Kanan serves as Senior Vice President, Chief Financial Officer of the Company since October 2015. Prior to joining Avadel, Mr. Kanan was employed by Sigma-Aldrich Corp. from April 2009 until November 2015, where he served as Vice President Finance, Corporate Controller and Chief Accounting Officer of Sigma-Aldrich from April 2009 until November 2015. Sigma-Aldrich is a life science and high technology company which was acquired by Merck KGaA, a health care, life science and performance materials company based in Germany, in November 2015. Mr. Kanan began his career at the international accounting firm Deloitte & Touche, and also held accounting and finance leadership positions with Hutchinson Group, a subsidiary of Total S.A., and Meritor, a global supplier of drivetrain, mobility, braking and aftermarket solutions for commercial vehicle and industrial markets. Mr. Kanan holds a Bachelor of Arts degree in Accounting from Michigan State University and became a CPA in 1987.

Basic Compensation

Total Annual Compensation, USD 1,041,750
Restricted Stock Award, USD 187,200
Long-Term Incentive Plans, USD --
All Other, USD 22,600
Fiscal Year Total, USD 1,251,550

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --